Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 8/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17039719 | 0.90 | CYP1B1 (0.33) | TERTPIN1PIN4 | |
| SCHEMBL305590 | 0.85 | TERT (0.47) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL30195004 | 0.85 | TERT (0.47) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL17483966 | 0.85 | TERT (0.36) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL2858238 | 0.84 | TERT (0.40) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL21975298 | 0.82 | TERT (0.39) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL15188864 | 0.81 | TERT (0.36) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL17514440 | 0.81 | KDM4E (0.40) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL44947 | 0.81 | CYP1B1 (0.38) | TERTSTAT3HIF1APIN1PIN4 | |
| SCHEMBL3042893 | 0.81 | TERT (0.38) | TERTSTAT3HIF1APIN1PIN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017006325-A1 | PERYLENE DIIMIDE BASED MEMBRANE AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-01-12 | — | — | WO | disclosed |
| EP-3112013-A1 | PERYLENE DIIMDE BASED MEMBRANE, PREPARATION AND RECYCLING THEREOF, AND USE FOR NANOPARTICLE SEPARATION THEREOF | Yeda Research and Development Co. Ltd (IL) | 2017-01-04 | — | — | EP | disclosed |
| EP-3067354-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | Yeda Research and Development Co. Ltd. (IL) | 2016-09-14 | — | — | EP | disclosed |
| US-20150240027-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240027-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | PIN1, PARN, DDT | TERT 216/4885STAT3 3096/4885HIF1A 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.